DOI: http://dx.doi.org/10.18203/2349-3933.ijam20202114

Evaluation of the predisposing factors and cause of resistance which are associated with ART 1 failure and shifted to ART 2 regime

Narendra Singh, R. K. Varma, Richa Giri, Punit Varma, Seema Dwivedi, Lalit Kumar

Abstract


Background: This study is to evaluate the predisposing factors and cause of resistance which are associated with ART1 failure and shifted to ART 2 regime.

Methods: This study was conducted in ART plus centre K.P.S. Post Graduate Institute of Medicine (G.S.V.M. Medical College, Kanpur, India) tertiary care teaching hospital (G.S.V.M. Medical College, Kanpur, India). It will be a clinical (assessment with investigation), continuous, longitudinal, prospective and retrospective, observational, single centre hospital-based study at ART Centre, Kanpur, India.  All the subjects who were on 1st line ART regime, attended in our centre were screened for treatment failure of based on clinical, immunological and virological criteria as decided by SACEP. Duration of this study was DEC 2016 TO DEC 2018.This study was taking as regime ART2 as TLATV/R, ZLATV/R, TLLP/R and ZLLP/R.

Results: In this study there is PL HIV subjects that are considered for ART2 are mostly living in rural area and more are female having less adherence to ART1. Smoking, alcohol and tobacco chewing were also having less adherence to ART and cause resistance to ART1.

Conclusions: In this study subjects were having associated with predisposing factor as Alcohalic 53 (45%), Tobacco Chewing 8 (07%), SMOKING 13 (11%). Alcohalic, Tobacco Chewer and Smoker have significant association of predisposing factor for low adherence to ART1 and resistance to ART1 drugs. There is also concluded that females and rural areas subject are having low adherence and cause ART1 failure.

 

Keywords


A-Atanzanavir, Antiretroviral therapy, Human immunodeficiency virus, L- Lamivudine, L-Lopinavir, R-Rotonavir, Sacep, T-Tenofovir, Z-Zaduvudine

Full Text:

PDF

References


Oldfield V, Plosker GL. Lopinavir/ritonavir. A review of its use in the management of HIV infection. Drugs. 2006;66:1275-99.

Kyser M, Buchacz K, Bush TJ, Conley LJ, Hammer J, Henry K, et al. Factors associated with non-adherence to antiretroviral therapy in the SUN study. AIDS care. 2011 May 1;23(5):601-11.

Shuter J, Bernstein SL. Cigaret smoking is an independant predictor of nonadharance in HIV- infected individuals receiving highly active antiretroviral therapy. Nicotine Tob Res. 2008 Apr;10(4):731-6.

Shuter J, Sarlo JA, Kanmaz TJ, Rode RA, Zingman BS. HIV-infected patients receiving lopinavir/ritonavir-based antiretroviral therapy achieve high rates of virologic suppression despite adherence rates less than 95%. JAIDS. 2007;45(1):4-8.

Patel D, Desai M,Shah AN, Dikshit RL. Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients. Perspect Clin Res. 2013 Oct-Dec; 4(4):215-20.

Fox MP, Van Cutsem G, Giddy J, Maskew M, Keiser O, Prozesky H, et al. Rates and predictors of failure of first-line antiretroviral therapy and switch to second-line ART in South Africa. Journal of acquired immune deficiency syndromes (1999). 2012 Aug 1;60(4):428.

Tsegaye AT, Wubshet M, Awoke T, Alene KA. Predictors of treatment failure on second-line antiretroviral therapy among adults in northwest Ethiopia: a multicentre retrospective follow-up study. BMJ open. 2016;6(12):e012537.

Billioux A, Nakigozi G, Newell K, Chang LW, Quinn TC, Gray RH, et al. Durable suppression of HIV-1 after virologic monitoring-based antiretroviral adherence counseling in Rakai, Uganda. PLoS One. 2015;10(5).

Davidson principle’s and practice of medicine, 22nd Edition; 2014.